Vectura Group Plc (VEC):企業の製品パイプライン分析

◆英語タイトル:Vectura Group Plc (VEC) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME7949PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥192,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥288,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vectura Group Plc (Vectura) is a formulation, device design and development company. It focuses on the development of inhaled airways products through an integrated inhaled drug delivery platform. Its major products include dry powder inhalers (DPI) and metered dose inhalers (MDI) for patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) and other ailments. The company develops products based on proprietary lung delivery technologies. It has partnership and license agreements with global biotechnology and pharmaceutical companies to develop a portfolio of drugs, including inhaled in-market products and inhaled generics. Vectura is headquartered in Chippenham, Wiltshire, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Vectura Group Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Vectura Group Plc Company Overview
Vectura Group Plc Company Snapshot
Vectura Group Plc Pipeline Products and Ongoing Clinical Trials Overview
Vectura Group Plc – Pipeline Analysis Overview
Business Description
Vectura Group Plc – Key Facts
Vectura Group Plc – Major Products and Services
Vectura Group Plc Pipeline Products by Development Stage
Vectura Group Plc Ongoing Clinical Trials by Trial Status
Vectura Group Plc Pipeline Products Overview
Digitally – Connected LOMI Device
Digitally – Connected LOMI Device Product Overview
Flutiform pMDI
Flutiform pMDI Product Overview
Open-Inhale-Close Dry Powder Inhaler
Open-Inhale-Close Dry Powder Inhaler Product Overview
SKP-2075
SKP-2075 Product Overview
VR475 Combination Device
VR475 Combination Device Product Overview
VR647
VR647 Product Overview
VR647 Clinical Trial
Vectura Group Plc – Key Competitors
Vectura Group Plc – Key Employees
Vectura Group Plc – Key Employee Biographies
Vectura Group Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Vectura Group Plc, Recent Developments
Jan 12, 2021: Vectura Group: Trading update
Apr 17, 2020: Vectura presents latest science at Digital RDD 2020
Nov 27, 2019: VR315US: Hikma submits response to FDA
Oct 29, 2019: Vectura Group appoints New Chief Executive Officer
Oct 22, 2019: Vectura to present latest science at Drug Delivery to the Lungs (DDL) 2019
Oct 04, 2019: UK court dismisses GSK’s claims of passing off in respect of Sandoz’s AirFluSal Forspiro
Sep 26, 2019: Vectura Group: Board Change
Sep 13, 2019: Vectura provides update on GSK Litigation
Sep 10, 2019: Vectura delivers strong financial performance for H1 2019 and confirms proposed special dividend of approximately £40m in aggregate plus a £20m buyback programme
Sep 10, 2019: Vectura Group interim results for the six months ended 30 June 2019
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Vectura Group Plc Pipeline Products and Ongoing Clinical Trials Overview
Vectura Group Plc Pipeline Products by Equipment Type
Vectura Group Plc Pipeline Products by Indication
Vectura Group Plc Ongoing Clinical Trials by Trial Status
Vectura Group Plc, Key Facts
Vectura Group Plc, Major Products and Services
Vectura Group Plc Number of Pipeline Products by Development Stage
Vectura Group Plc Pipeline Products Summary by Development Stage
Vectura Group Plc Ongoing Clinical Trials by Trial Status
Vectura Group Plc Ongoing Clinical Trials Summary
Digitally - Connected LOMI Device - Product Status
Digitally - Connected LOMI Device - Product Description
Flutiform pMDI - Product Status
Flutiform pMDI - Product Description
Open-Inhale-Close Dry Powder Inhaler - Product Status
Open-Inhale-Close Dry Powder Inhaler - Product Description
SKP-2075 - Product Status
SKP-2075 - Product Description
VR475 Combination Device - Product Status
VR475 Combination Device - Product Description
VR647 - Product Status
VR647 - Product Description
VR647 - A Phase I Clinical Study of VR-647
VR647 - A Phase I Clinical Study of VR-647 in Adult Asthma Subjects
VR647 - Phase II Pharmacokinetic Study of VR-647 in Children
VR647 - Phase III Study of VR-647
Vectura Group Plc, Key Employees
Vectura Group Plc, Key Employee Biographies
Vectura Group Plc, Other Locations
Vectura Group Plc, Subsidiaries
Glossary

★海外企業調査レポート[Vectura Group Plc (VEC):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Elos Medtech AB (ELOS B):医療機器:M&Aディール及び事業提携情報
    Summary Elos Medtech AB (Elos Medtech) is a partner in development and manufacturer of medical devices and components. The company’s products include dental and orthopedic implants and instruments. It offers diagnostic devices used in the treatment of diabetes, neurosurgery, heart surgery and hearin …
  • Cintas Corp (CTAS):企業の財務・戦略的SWOT分析
    Cintas Corp (CTAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Bemis Company Inc (BMS):企業の財務・戦略的SWOT分析
    Bemis Company Inc (BMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Albireo Pharma Inc (ALBO):企業の財務・戦略的SWOT分析
    Albireo Pharma Inc (ALBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Toshiba America Medical Systems Inc:製品パイプライン分析
    Summary Toshiba America Medical Systems Inc (TAMS), a subsidiary of Toshiba Medical Systems Corp, is a medical device company which markets and distributes the diagnostic imaging systems. The company offers cardiovascular X-ray, computed tomography, angiography, magnetic resonance, ultrasound and x- …
  • United States Postal Service:企業の戦略的SWOT分析
    United States Postal Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Empyrean Energy PLC (EME):企業の財務・戦略的SWOT分析
    Summary Empyrean Energy PLC (Empyrean Energy) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company's projects include China Block 29/11 project, Duyung PSC project, and Sacramento Basin Projects. Its Duyung PSC project covers a …
  • NTT Data Corporation:企業のM&A・事業提携・投資動向
    NTT Data Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NTT Data Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Jiangsu Hengrui Medicine Co Ltd (600276):製薬・医療:M&Aディール及び事業提携情報
    Summary Jiangsu Hengrui Medicine Co Ltd (Jiangsu Hengrui) is a biopharmaceutical company that focuses on the research, development, manufacture and distribution of novel pharmaceutical products. Its product portfolio includes antineoplastic products, anti-tumor drugs, surgical drugs and contrast age …
  • Mitsubishi Heavy Industries, Ltd.:戦略・SWOT・企業財務分析
    Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Heavy Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Ipsen SA (IPN):製薬・医療:M&Aディール及び事業提携情報
    Summary Ipsen SA (Ipsen) is a global specialty biopharmaceutical company that manufactures and distributes drugs for the treatment of cancer and rare and neurological diseases. The company develops and commercializes novel medicines in cancer, neuroscience and rare diseases. It also offers products …
  • CPFL Energia SA (CPFE3):電力:M&Aディール及び事業提携情報
    Summary CPFL Energia S.A. (CPFL), formerly Companhia Paulista de Forca e Luz, is an electric utility, which carries out regulated and non-regulated electricity business. The company through its subsidiaries generates, transmits, distributes and commercializes electricity. It generates electricity us …
  • Publix Super Markets Inc (PUSH):企業の財務・戦略的SWOT分析
    Publix Super Markets Inc (PUSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Usha Martin Limited:企業の戦略・SWOT・財務情報
    Usha Martin Limited - Strategy, SWOT and Corporate Finance Report Summary Usha Martin Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sumatec Resources Berhad (SUMATEC):石油・ガス:M&Aディール及び事業提携情報
    Summary Sumatec Resources Berhad (Sumatec) is an oilfield service provider that offers of construction and drilling services to the oil and gas industry. The company’s services include engineering and construction for oil and gas facilities, oil and gas assets development, supply and management of o …
  • AirStrip Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary AirStrip Technologies Inc (AirStrip) is a healthcare solution provider that offers medical software solutions and services. The company offers mobile interoperability platform interoperability platform that offers access to critical patient data and intelligent insights across the care conti …
  • Aon Plc:企業の戦略・SWOT・財務分析
    Aon Plc - Strategy, SWOT and Corporate Finance Report Summary Aon Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Heidelberg Engineering GmbH:製品パイプライン分析
    Summary Heidelberg Engineering GmbH (Heidelberg Engineering) is a imaging solutions provider that develops, manufactures and distributes diagnostic devices for ophthalmology practice. The company offers various diagnostic instruments for eye care professionals. Its products comprise spectralis, HEP, …
  • LGC Ltd:医療機器:M&Aディール及び事業提携情報
    Summary LGC Ltd (LGC), formerly LGC (Teddington) Ltd is a life sciences measurement and testing company that offers reference materials, genomics solutions and analytical testing products and services. The company’s products comprise DNA extraction instrumentation, DNA extraction kits, Douglas scien …
  • BrainLAB AG:企業の戦略的SWOT分析
    BrainLAB AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆